Bo T. Lindmark
BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mineralocorticoid Receptor Antagonists With an Acylurea as a Key Polar Interaction Motif.
Journal: ChemMedChem
Published: November 19, 2025
Meeting report: DMDG peptide and oligonucleotide ADME workshop 2024.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: May 20, 2025
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participants.
Journal: Pharmacology research & perspectives
Published: March 21, 2024
Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection.
Journal: Journal of medicinal chemistry
Published: January 01, 2019
Accelerated drug discovery by rapid candidate drug identification.
Journal: Drug discovery today
Published: November 23, 2018
Human hepatocytes and cytochrome P450-selective inhibitors predict variability in human drug exposure more accurately than human recombinant P450s.
Journal: British journal of pharmacology
Published: August 08, 2017
Time dependent analysis of assay comparability: a novel approach to understand intra- and inter-site variability over time.
Journal: Journal of computer-aided molecular design
Published: November 13, 2014
Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687).
Journal: Journal of medicinal chemistry
Published: November 03, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026